A rare chronic myeloid leukemia case with Philadelphia chromosome, BCR-ABL e13a3 transcript and complex translocation involving four different chromosomes
- PMID: 22966382
- PMCID: PMC3436393
- DOI: 10.3892/ol_00000139
A rare chronic myeloid leukemia case with Philadelphia chromosome, BCR-ABL e13a3 transcript and complex translocation involving four different chromosomes
Abstract
The so-called Philadelphia (Ph) chromosome is present in more than 90% of chronic myeloid leukemia (CML) patients. Around 5-10% of these patients show complex translocations involving other chromosomes in addition to and/or besides chromosomes 9 and 22. CML cases with fusion transcripts, such as e13a3, in which ABL exon 3 rather than exon 2 has fused to BCR, are extremely rare. Such reported cases with the e13a3 transcript showed the Ph chromosome on karyotype analysis. This study reported a rare Ph chromosome-positive CML case with new complex chromosomal aberrations and an e13a3 BCR-ABL transcript that has yet to be established. A four-chromosome translocation involving chromosomal regions 12p11.2, 19q13.3, 9q34.1 and 22q11.2, besides a trisomy 8 and a derivative chromosome 12, were identified using high resolution multicolor banding. Reverse transcription polymerase chain reaction products showed the presence of BCR-ABL fusion transcript e13a3, and this signifies the major BCR breakpoint. The significance of the observed rearrangements and their possible role in the progression of CML was investigated.
Figures



Similar articles
-
A chronic myeloid leukemia patient with atypical karyotype and BCR-ABL e13a3 transcript caused by complex chromosome rearrangement.Int J Hematol. 2009 Sep;90(2):230-234. doi: 10.1007/s12185-009-0368-4. Epub 2009 Jun 30. Int J Hematol. 2009. PMID: 19565180
-
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.Acta Haematol. 2002;107(2):76-94. doi: 10.1159/000046636. Acta Haematol. 2002. PMID: 11919388 Review.
-
A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD).Leuk Res. 2017 Aug;59:8-11. doi: 10.1016/j.leukres.2017.05.009. Epub 2017 May 12. Leuk Res. 2017. PMID: 28527402
-
Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.Haematologica. 2000 Jan;85(1):35-9. Haematologica. 2000. PMID: 10629589
-
Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.Leuk Res. 1999 Mar;23(3):207-15. doi: 10.1016/s0145-2126(98)00171-4. Leuk Res. 1999. PMID: 10071072 Review.
Cited by
-
Three-way Philadelphia translocation t(9;10;22)(q34;p11.2;q11.2) as a secondary abnormality in an imatinib mesylate-resistant chronic myeloid leukemia patient.Oncol Lett. 2013 May;5(5):1656-1658. doi: 10.3892/ol.2013.1228. Epub 2013 Mar 5. Oncol Lett. 2013. PMID: 23759955 Free PMC article.
-
Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities.J Cell Mol Med. 2014 Jul;18(7):1239-46. doi: 10.1111/jcmm.12319. Epub 2014 Jun 9. J Cell Mol Med. 2014. PMID: 24912534 Free PMC article. Review.
-
Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion.Ann Lab Med. 2016 May;36(3):287-9. doi: 10.3343/alm.2016.36.3.287. Ann Lab Med. 2016. PMID: 26915625 Free PMC article. No abstract available.
-
A new t(9;11;20;22)(q34;p11.2;q11.21;q11) in a Philadelphia-positive chronic myeloid leukemia case.Oncol Lett. 2013 Feb;5(2):605-608. doi: 10.3892/ol.2012.1039. Epub 2012 Nov 21. Oncol Lett. 2013. PMID: 23420768 Free PMC article.
-
The spectrum of chromosomal translocations in the Arab world: ethnic-specific chromosomal translocations and their relevance to diseases.Chromosoma. 2022 Sep;131(3):127-146. doi: 10.1007/s00412-022-00775-2. Epub 2022 Jul 30. Chromosoma. 2022. PMID: 35907041 Free PMC article.
References
-
- Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature. 1985;315:550–554. - PubMed
-
- Deiningger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood. 2000;96:3343–3356. - PubMed
-
- Al-Ali HK, Leiblein S, Kovacs I, Hennig E, Niederwieser D, Deininger MW. CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall. Blood. 2002;100:1092–1093. - PubMed
-
- Liu LG, Tanaka H, Ito K, Kyo T, Ito T, Kimura A. Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3. Am J Hematol. 2003;74:268–272. - PubMed
-
- Snyder DS, McMahon R, Cohen SR, Slovak ML. Chronic myeloid leukemia with e13a3 BCR-ABL fusion: benign course responsive to imatinib with an RT-PCR advisory. Am J Hematol. 2004;75:92–95. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous